Inactive Instrument

Analyst Reco. U.S. Physical Therapy, Inc. Nasdaq

Equities

US90337L1089

Real-time Estimate Cboe BZX Other stock markets 02:31:20 2024-06-07 pm EDT			5-day change	1st Jan Change
96.82 ^USD	0.00%		0.00%	0.00%

May. 21	U.S. Physical Therapy, Inc. Announces Board Changes	CI
May. 16	U S Physical Therapy Insider Sold Shares Worth $268,925, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

U S Physical Therapy Insider Sold Shares Worth $268,925, According to a Recent SEC Filing	May. 16	MT
JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating	Mar. 13	MT
Barrington Ups Price Target on U.S. Physical Therapy to $122 From $120 After Strong Q4 Beat, Keeps Outperform Rating	Mar. 01	MT
Barrington Adjusts Price Target on U.S. Physical Therapy to $120 From $111, Maintains Outperform Rating	Jan. 03	MT
JPMorgan Adjusts Price Target on U.S. Physical Therapy to $99 From $108, Maintains Overweight Rating	Nov. 17	MT
Barrington Cuts Price Target on U.S. Physical Therapy to $111 From $124 on 'Tough Stock Market Environment', Reiterates Outperform Rating	Nov. 09	MT
JPMorgan Starts US Physical Therapy at Overweight With $108 Price Target	23-09-22	MT
CJS Securities Upgrades US Physical Therapy to Market Outperform From Market Perform, $120 Price Target	23-09-19	MT
Jefferies Adjusts U.S. Physical Therapy Price Target to $130 From $145, Maintains Buy Rating	23-09-15	MT
Barrington Boosts Price Target on U.S. Physical Therapy to $124 From $116, Keeps Outperform Rating	23-08-14	MT
BofA Securities Initiates U.S. Physical Therapy With Buy Rating, $138 Price Target	23-06-30	MT
Barrington Research Adjusts Price Target on U.S. Physical Therapy to $110 From $107, Maintains Outperform Rating	23-02-24	MT
Barrington Research Lowers U.S. Physical Therapy's Price Target to $107 From $123, Maintains Outperform Rating	22-08-05	MT
Barrington Research Trims US Physical Therapy's Price Target to $123 From $144, Maintains Outperform Rating	22-02-25	MT
Barrington Adjusts Price Target on US Physical Therapy to $144 From $142, Maintains Outperform Rating	22-01-03	MT
CJS Securities Upgrades U.S. Physical Therapy to Outperform From Market Perform, Lower Price Target to $120 From $126	21-12-14	MT
Barrington Adjusts Price Target on US Physical Therapy to $142 From $139 on Long-Term Confidence, Maintains Outperform Rating	21-12-10	MT
Sidoti Upgrades U.S. Physical Therapy to Buy From Neutral, Keeps $124 Price Target	21-11-22	MT
U S PHYSICAL THERAPY : Barrington Adjusts Price Target on U.S. Physical Therapy to $139 From $130 After 'Exceptionally Strong Q2', Maintains Outperform Rating	21-08-06	MT
U S PHYSICAL THERAPY : Barrington Research Upgrades U.S. Physical Therapy to Outperform From Market Perform, $130 Price Target	21-05-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. U.S. Physical Therapy, Inc. Nasdaq

Equities

US90337L1089

Analyst Reco.

Filters